PPT-January 2015 Medicare Benefits, Options, and Transitions Rules for People with ESRD
Author : mitsue-stanley | Published Date : 2018-10-25
Audio Portion 18667401260 Web Portion wwwReadyTalkcom Code 4796976 Please join us online at wwwReadyTalkcom Follow Along with Us Online Lines are Muted During the
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "January 2015 Medicare Benefits, Options,..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
January 2015 Medicare Benefits, Options, and Transitions Rules for People with ESRD: Transcript
Audio Portion 18667401260 Web Portion wwwReadyTalkcom Code 4796976 Please join us online at wwwReadyTalkcom Follow Along with Us Online Lines are Muted During the Webinar Weve muted all the lines to help eliminate background noise as much as possible. Use these steps to help you decide which way to get your coverage Part Hospital Insurance Part Medical Insurance Medicare Supplement Insurance Medigap policy Part D Prescription Drug Coverage Part C Combines Part57373A Part57373B and usually Part D ESRD Patient Management. Improving Handoffs. Antonia Harford, MD. UNM Nephrology. OBJECTIVES. Review Epidemiology of ESRD. Mortality/Hospitalization in ESRD. Transitions of care in ESRD: . Discharge Handoffs . Hosp. -based, hospital-based dialysis centers; . Indep. , independent dialysis providers; SDO, small dialysis organizations.. v. ol 2 Figure . 8.1 Dialysis units & patient counts, by unit affiliation, . vol. 2 Figure 5.1 Adjusted all-cause mortality rates, overall and by modality. Vol. 2, ESRD, . Ch. 5. 3. Data Source: Reference Tables H.4, H.8, H.9, and H.10, and special analyses, USRDS ESRD Database. Adjusted for age, sex, race, and primary diagnosis. Ref: 2011 patients. Abbreviation: ESRD, end-stage renal disease.. 2012-2014. (a) Denominator excludes missing/unknown causes of death. 2016 Annual Data Report, Vol . 2, ESRD. , . Ch. . 9. 2. Data Source: Special analysis using Reference Table H12. . Denominator . includes other causes of death and excludes missing/unknown causes of death (24.7% of patients have unknown or missing causes of death. (bars; scale on right), and annual change (%) in the adjusted* incidence rate of ESRD . (lines; scale on left) in the U.S. population, 1996-2013. Vol 2, ESRD, Intro. 2. Data Source: Reference Table A.2(2) and special analyses, USRDS ESRD Database. *Adjusted for age, sex, and race.. Figure . 13.1 . Geographic variations in the incidence of treated ESRD . per . million population, by country, 2013. Vol 2, ESRD, . Ch. 13. 2. Data . Source. : . Special analyses, USRDS ESRD Database. Data presented only for countries from which relevant information was available. All rates are unadjusted. ^United Kingdom: England, Wales, Northern Ireland (Scotland data reported separately). Data for Belgium do not include patients younger than 20. Data for Indonesia represent the West Java region. Data for France include 22 regions. Data for Spain include 18 of 19 regions. Abbreviations: ESRD, end-stage renal disease; sp., speaking.. and Young Adults. 2017 . Annual Data Report. Volume 2: End-Stage Renal Disease. 2. vol 2 Figure 7.1 (a) Incidence and, (b) December 31. st. point prevalence of ESRD among pediatric patients (aged 0–21 years), by modality, 1996-2015. 463 Chapter 7 : ESRD among Children, Adolescents, and Young Adults The number of children and adolescents beginning end - stage renal disease ( ESRD ) care is steadily decreasing from a high Hosp. -based, hospital-based dialysis centers; . Indep. , independent dialysis providers; SDO, small dialysis organizations.. . Figure . 10.1 Dialysis unit counts, by unit affiliation, 2010–2013. Vol 2, ESRD, . Figure . 7.1 . Sources of prescription drug coverage in Medicare enrollees, by population, 2014. 2016 Annual Data Report, Vol 1, CKD, Ch . 7. 2. a The . catastrophic coverage amount is the greater of 5% of medication cost or the values shown in the chart above. In 2014, beneficiaries were charged $2.55 for those generic or preferred multisource drugs with a retail price less than $51 and 5% for those with a retail price over $51. For brand name drugs, beneficiaries paid $6.35 for those drugs with a retail price less than $127 and 5% for those with a retail price over $127. Table adapted from http://www.q1medicare.com/PartD-The-2014-Medicare-Part-D-Outlook.php. . 2017 . Annual Data Report. Volume 2: End-Stage Renal Disease. 2. vol 2 Figure 8.1 Prevalence of cardiovascular diseases in adult ESRD patients, by treatment modality, 2015. Data Source: Special analyses, USRDS ESRD Database. Point prevalent hemodialysis, peritoneal dialysis, and transplant patients aged 22 and older, who are continuously enrolled in Medicare Parts A and B, and with Medicare as primary payer from January 1, 2015 to December 31, 2015, and ESRD service date is at least 90 days prior to January 1, 2015. Abbreviations: AF, atrial fibrillation; AMI, acute myocardial infarction; CAD, coronary artery disease; CVA/TIA, cerebrovascular accident/transient ischemic attack; CVD, cardiovascular disease; HF, heart failure; PAD, peripheral arterial disease; SCA/VA, sudden cardiac arrest and ventricular arrhythmias; VHD, . Af. Am, African American; AKI, acute kidney injury; CKD, chronic kidney disease.. vol. 2 Table 2.1 HP2020 CKD-3 Increase the proportion of hospital patients who incurred acute kidney injury who have follow-up renal evaluation in 6 months post-discharge: Target 12.3%.
Download Document
Here is the link to download the presentation.
"January 2015 Medicare Benefits, Options, and Transitions Rules for People with ESRD"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents